Pharmacology (death) PhD Projects, Programmes & Scholarships

We have 21 Pharmacology (death) PhD Projects, Programmes & Scholarships

Inducing ferroptotic death to kill cancer cells

The University of Manchester Faculty of Biology, Medicine and Health

Ferroptosis is an iron-dependent form of regulated necrotic cell death triggered by oxidative degradation of lipids in membrane bilayers and subsequent irreparable damages to the plasma membrane (1). Read more

Supervisors: Dr C Tournier, Dr K Finegan

Year round applications PhD Research Project Self-Funded PhD Students Only

More Details

SLS 3: Investigating the anti-inflammatory effects of artemisinin compounds on macrophages under systemic inflammatory conditions

University of Westminster School of Life Sciences

Artemisinin compounds are safe and effective antimalarials. Recent evidence in our lab has shown these compounds also exert a potent anti-inflammatory effect by inhibiting neutrophil migration and the release of cytokines, chemokines and neutrophil extracellular traps. Read more

Supervisors: Dr HM Morad, Dr CM Moore, Dr IL Locke

17 May 2024 PhD Research Project Funded PhD Project (UK Students Only)

More Details

Development of miRNAs as a new therapeutic tool in the treatment of cardiovascular diseases

Semmelweis University Budapest Department of Pharmacology and Pharmacotherapy

Ischemic heart diseases and their pathological consequences belong to the leading causes of death worldwide. In the acute treatment of myocardial ischemia one of the most important tasks is the restoration of the tissue perfusion. Read more

Supervisor: Prof P Ferdinandy

Year round applications PhD Research Project Funded PhD Project (European/UK Students Only)

More Details

(MRC DTP CASE) Understanding how tumour associated macrophages control the tumour immune landscape in NF2-Schwannomatosis

The University of Manchester Faculty of Biology, Medicine and Health

Type 2 Neurofibromatosis (NF2), now referred to as NF2-Schwannomatosis (or NF2-SWN), is a rare autosomal dominant tumour pre-disposition syndrome characterised by growth of typically benign tumours throughout the nervous system. Read more

Supervisors: Prof D Brough, Dr K Couper

13 May 2024 PhD Research Project Competition Funded PhD Project (UK Students Only)

More Details

Engineering functional human tissue: Development of a 3D cerebral microvascular model with blood brain barrier function.

University of Strathclyde Department of Biomedical Engineering

There is mounting research interest in tissue engineered models of human blood brain barrier (BBB) due to the prevalence of central nervous system (CNS) disease in modern societies. Read more

Supervisors: Dr J Wu, Prof W Shu

15 May 2024 PhD Research Project Funded PhD Project (Students Worldwide)

More Details

Understanding sleep disturbance in clients seeking treatment for alcohol use disorder

Monash University Medicine, Nursing and Health Sciences

Alcohol use disorder (AUD) is a leading cause of injury and chronic disease and mortality in Australia, and the leading cause of disability or death for those aged 15-49, the most economically productive sector of society. Read more

Supervisors: Prof DL Lubman AM, Prof VM Manning, Assoc Prof SA Arunogiri, Dr RO Ogeil

Year round applications PhD Research Project Funded PhD Project (Students Worldwide)

More Details

Last chance to apply

Understanding the benefits and risks of the therapeutic targeting of the Nrf2 stress response

University of Liverpool Institute of Systems, Molecular and Integrative Biology

This studentship is fully funded for 4 years and is due to start in October 2024. Important. the tuition fee element of the studentship covers the fee rate for UK students only. Read more

Supervisor: Prof I Copple

19 April 2024 PhD Research Project Funded PhD Project (UK Students Only)

More Details

Quantifying the risk of precipitating drug induced crystalluria (XTALURIA)

Newcastle University School of Pharmacy

The growth of crystals in the body often results in pain, damage, and gross harm. Read more

Supervisor: Dr O Kavanagh

Year round applications PhD Research Project Self-Funded PhD Students Only

More Details

Therapeutic resolution of pulmonary arterial hypertension (PAH) by natural products

University of Bradford Faculty of Life Sciences

Research Group: Pharmacology and Experimental Therapeutics

Pulmonary arterial hypertension (PAH) is a devastating cardiovascular disorder which, if left untreated, leads to heart failure and death. Read more

Supervisors: Dr T Nasim, Prof C Wright

Year round applications PhD Research Project Self-Funded PhD Students Only

More Details

Development of a personalized therapy for pulmonary arterial hypertension (PAH)

University of Bradford Faculty of Life Sciences

Research Group: Pharmacology and Experimental Therapeutics

Pulmonary arterial hypertension (PAH) is a devastating cardiovascular disorder which, if left untreated, leads to heart failure and death. Read more

Supervisor: Dr T Nasim

Year round applications PhD Research Project Self-Funded PhD Students Only

More Details

Therapeutic resolution of BMPR2-mediated signalling defects in pulmonary arterial hypertension (PAH)

University of Bradford Faculty of Life Sciences

Research Group: Pharmacology and Experimental Therapeutics

Pulmonary arterial hypertension (PAH) is an incurable and devastating disease and death occurs within 2.5 years of diagnosis. Read more

Supervisors: Dr T Nasim, Dr R Gopalan

Year round applications PhD Research Project Self-Funded PhD Students Only

More Details

Re-purposing established drugs for the resolution of pulmonary arterial hypertension (PAH)

University of Bradford Faculty of Life Sciences

Research Group: Pharmacology and Experimental Therapeutics

Pulmonary arterial hypertension (PAH) is a devastating cardiovascular disorder which, if left untreated, leads to heart failure and death. Read more

Supervisors: Dr T Nasim, Dr K Assi

Year round applications PhD Research Project Self-Funded PhD Students Only

More Details

Developing novel therapeutic strategies to better treat Triple Negative Breast Cancer

Queen’s University Belfast School of Pharmacy

One in two people will develop cancer in their lifetime and it is a leading cause of death. While significant progress has been made in the treatment of some cancers, there still remain some forms of the disease with limited treatment options and poor outcome. . Read more

Supervisor: Dr N Buckley

Year round applications PhD Research Project Self-Funded PhD Students Only

More Details

Personalising cancer treatment with tumour evolution modelling using AI-based genomics biomarkers and PK/PD

University of Liverpool Institute of Systems, Molecular and Integrative Biology

Tumour heterogeneity is a major problem limiting the efficacy of targeted oncological therapies. Most advanced tumours eventually become resistant to the treatments, ultimately making the patient succumb to metastatic disease. Read more

Supervisor: Dr T You

1 August 2024 PhD Research Project Self-Funded PhD Students Only

More Details

Determining the biocompatibility of, novel, nano-silica coated surfaces on oral and gastrointestinal immune barriers

University of Liverpool Department of Pharmacology and Therapeutics

The interaction of nanoparticles with cells, particularly those that are immune-competent, may affect their biocompatibility, particularly when applied in long-term situations. Read more

Supervisors: Dr N Liptrott, Prof R Williams

Year round applications PhD Research Project Self-Funded PhD Students Only

More Details

We have 21 Pharmacology (death) PhD Projects, Programmes & Scholarships

Pharmacology (death) PhD Projects, Programmes & Scholarships

We have 21 Pharmacology (death) PhD Projects, Programmes & Scholarships

Select your nearest city

Do you want hassle-free information and advice?